Amicogen Inc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.027x

Amicogen Inc cash flow conversion efficiency. Based on the latest financial reports, Amicogen Inc (092040) has a cash flow conversion efficiency ratio of -0.027x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.58 Billion ≈ $-2.43 Million USD) by net assets (₩133.35 Billion ≈ $90.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Amicogen Inc (2014–2025)

Cash flow conversion efficiency of Amicogen Inc from 2014 to 2025. This chart illustrates how Amicogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Amicogen Inc for real-time trading data and today's change.

Amicogen Inc Cash Flow Conversion Ratio Explained

Amicogen Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Amicogen Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amicogen Inc ranked by their cash flow conversion efficiency. Also see 092040 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Theralase Technologies Inc. V:TLT	-0.180x
Shinil Electronics Co KO:002700	-0.059x
Advani Hotels & Resorts (India) Limited NSE:ADVANIHOTR	0.016x
Touchstone Exploration Inc TO:TXP	0.068x
Grazziotin S.A SA:CGRA3	0.028x
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	0.003x
Nila Spaces Limited NSE:NILASPACES	-0.017x
Lay Hong Bhd KLSE:9385	0.018x

Annual Cash Flow Conversion Efficiency for Amicogen Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Amicogen Inc from 2014 to 2025. Review cash generation quality of Amicogen Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩95.86 Billion ≈ $64.96 Million	₩-24.42 Billion ≈ $-16.55 Million	-0.255x	-134.05%
2024-12-31	₩122.50 Billion ≈ $83.01 Million	₩-13.34 Billion ≈ $-9.04 Million	-0.109x	-375.82%
2023-12-31	₩218.97 Billion ≈ $148.40 Million	₩8.64 Billion ≈ $5.86 Million	0.039x	+123.21%
2022-12-31	₩131.80 Billion ≈ $89.32 Million	₩-22.41 Billion ≈ $-15.19 Million	-0.170x	-492.13%
2021-12-31	₩186.16 Billion ≈ $126.16 Million	₩8.07 Billion ≈ $5.47 Million	0.043x	-25.19%
2020-12-31	₩152.94 Billion ≈ $103.65 Million	₩8.87 Billion ≈ $6.01 Million	0.058x	-19.24%
2019-12-31	₩122.05 Billion ≈ $82.71 Million	₩8.76 Billion ≈ $5.94 Million	0.072x	+221.69%
2018-12-31	₩127.28 Billion ≈ $86.26 Million	₩2.84 Billion ≈ $1.92 Million	0.022x	-83.25%
2017-12-31	₩89.19 Billion ≈ $60.44 Million	₩11.88 Billion ≈ $8.05 Million	0.133x	-3.68%
2016-12-31	₩81.54 Billion ≈ $55.26 Million	₩11.28 Billion ≈ $7.64 Million	0.138x	-8.00%
2015-12-31	₩82.10 Billion ≈ $55.64 Million	₩12.34 Billion ≈ $8.36 Million	0.150x	+69.90%
2014-12-31	₩50.02 Billion ≈ $33.90 Million	₩4.43 Billion ≈ $3.00 Million	0.088x	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.78 Million

₩64.61 Billion KRW

Market Cap Rank

#22213 Global

#1406 in Korea

Share Price

₩917.00

Change (1 day)

+0.11%

52-Week Range

₩822.00 - ₩3125.00

All Time High

₩22094.22